TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TLSI

TriSalus Life Sciences Inc.

Healthcare · Medical Devices

4.90$ -0.6% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns TriSalus Life Sciences Inc. (TLSI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 80.4% of the shares are freely tradable; institutional investors hold 34.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 34.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 33.9%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 80.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 62Mio.

Largest Shareholders

Institutions

Institutions TLSI
Name Stake (%) Shares Change (%) Date
First Light Asset Management, LLC 10.64 6,552,491 +29.3 06/30/2026
Awm Investment Company Inc 3.38 2,079,105 +67.2 03/31/2026
Nantahala Capital Management, LLC 3.36 2,070,827 +0.0 03/31/2026
BlackRock Inc 2.44 1,499,547 -2.3 03/31/2026
Vanguard Capital Management, LLC 2.19 1,347,036 +0.0 03/31/2026
Gilder Gagnon Howe & CO LLC 1.44 888,515 -9.2 03/31/2026
HPM Partners LLC 1.28 787,272 +0.0 03/31/2026
Geode Capital Management, LLC 1.26 777,094 +3.4 03/31/2026

Funds

Funds TLSI
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.85 1,141,870 +0.0 07/31/2026
iShares Russell 2000 ETF 1.79 1,100,191 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?